CASI Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement Between EntreMed, Inc. and Celgene Corporation Dated March 23, 2005
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
DE
2005
License and Development Agreement for CB-5339 between Cleave Therapeutics, Inc. and CASI Pharmaceuticals, Inc.
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2021
License Agreement between Talon Therapeutics, Inc. and CASI Pharmaceuticals, Inc. for Marqibo®
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
License Agreement between Spectrum Pharmaceuticals Cayman, L.P. and CASI Pharmaceuticals, Inc. for Ibritumomab Tiuxetan Product
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
NY
2021
License Agreement between Spectrum Pharmaceuticals, Inc. and CASI Pharmaceuticals, Inc. for Melphalan Product
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
CA
2021
Supplementary Agreement to Exclusive License Agreement between Juventas Cell Therapy Ltd. and CASI Pharmaceuticals, Inc.
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
2020
Exclusive License Agreement between Juventas Cell Therapy Ltd. and CASI Pharmaceuticals, Inc. (June 15, 2019)
License Agreements
CASI Pharmaceuticals, Inc.
Biotechnology
MD
2019